Category: Health & Medicines > Medicines > Glipizide
Country/Region: China State/Province: Jiangsu
Main Products: Glipizide, Flunarizine Hydrochloride, Terazosin Hydrochloride, Benzenesulfonamide, Piperazine
Business Type: Exporter, Trader
Year Established: 2003
Employees: 501 - 1000 People
Plant Area: 3,000-5,000 square meters
Fax: 86-519-5123729
Main Markets: South America 12% Africa 12% Eastern Asia 8% Domestic Market 9% North America 10% Eastern Europe 9% Southern Europe 12% Mid East 8% Northern Europe 12% Oceania 8%
Trade Capacity: FOB, FCA, DAF
Contract Manufacturing: Design Service Offered
Nearest Port: Changzhou
Annual Revenue: US$10 Million - US$50 Million
Total Revenue: US$10 Million - US$50 Million
Export Revenue: US$5 Million - US$10 Million
Annual Output: confidential
Registered Capital: Below US$1 Million
Export Percentage: 1% - 10%
Payment Modes: USD, EUR, GBP
Lead Time: 25 days
Import/Export Mode: Have Own Export License